Close
American Drug Delivery & Formulation Summit
Xylem

Press Releases

BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa

BioNTech SE has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution. At a...

Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, announced that it plans to expand its Waigaoqiao Free Trade Zone (FTZ) facility...

Resilience Establishes Multi-Product Development and Manufacturing Collaboration with Takeda’s Plasma-Derived Therapies Business Unit

National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takedaโ€™s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture...

Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical trials

Velocity Clinical Research, the largest fully integrated clinical site organization, announces three key tech investments to expand its patient community, increase client engagement, and speed up drug development across all its 30 integrated locations. In the past 12 months, Velocity...

PHARMINTECH and IPACK-IMA: a synergic union

The 7thedition of Pharmintech Exhibition is goingto take place in Milan from May 3 to 6, 2022 in conjunction with IPACK-IMA, the most important international trade fair in 2022 for processing and packaging solutions. The two events will combine into...

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules in Colombia

Glenmark Pharmaceuticals, an innovationโ€“driven, global pharmaceutical company, announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and AstraZeneca Colombia S.A.S. have entered into an exclusive licensing agreement for the commercialization of AstraZeneca's drug Pulmicort Respulesยฎ. Under the terms of the...

Envirotainer introduces the RAP for the future – part of the Releye series

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, launched its latest innovation, the Releyeยฎ RAP. This is complemented by the new Control Tower managed service. The Releyeยฎ RAP sets a new benchmark for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป